Delta Financial Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History
Delta Financial Advisors LLC
- $258 Million
- Q2 2024
A detailed history of Delta Financial Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Delta Financial Advisors LLC holds 1,395 shares of REGN stock, worth $1.39 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
1,395
Previous 1,395
-0.0%
Holding current value
$1.39 Million
Previous $1.34 Million
9.24%
% of portfolio
0.57%
Previous 0.53%
Shares
15 transactions
Others Institutions Holding REGN
# of Institutions
1,464Shares Held
84.4MCall Options Held
907KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$8.96 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$8.41 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$8.24 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.82 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$4.62 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $107B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...